Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Common Equity (2016 - 2025)

Neuronetics (STIM) has disclosed Common Equity for 10 consecutive years, with $26.2 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 17.48% to $26.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.2 million through Dec 2025, down 17.48% year-over-year, with the annual reading at $26.2 million for FY2025, 17.48% down from the prior year.
  • Common Equity for Q4 2025 was $26.2 million at Neuronetics, down from $31.4 million in the prior quarter.
  • The five-year high for Common Equity was $102.0 million in Q1 2021, with the low at $9.4 million in Q3 2024.
  • Average Common Equity over 5 years is $51.2 million, with a median of $42.5 million recorded in 2023.
  • The sharpest move saw Common Equity plummeted 75.27% in 2024, then skyrocketed 234.29% in 2025.
  • Over 5 years, Common Equity stood at $85.2 million in 2021, then crashed by 33.01% to $57.1 million in 2022, then plummeted by 40.08% to $34.2 million in 2023, then decreased by 6.99% to $31.8 million in 2024, then fell by 17.48% to $26.2 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $26.2 million, $31.4 million, and $31.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.